Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab-Reference-Cited by-同舟云学术

Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab

Published:2021-05-29 Issue:9 Volume:76 Page:2809-2826
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Manohar Monali¹,Dunham Diane¹,Gupta Sheena²,Yan Zheng¹,Zhang Wenming¹,Minnicozzi Samantha³⁴,Kirkey Matthew¹,Bunning Bryan¹,Roy Chowdhury Roshni⁵,Galli Stephen J.¹⁵⁶^ORCID,Boyd Scott D.¹⁶,Kost Laurie Elizabeth¹,Chinthrajah R. Sharon¹^ORCID,Desai Manisha⁷,Oettgen Hans C.³⁴,Maecker Holden T.²⁵,Yu Wong¹,DeKruyff Rosemarie H.¹^ORCID,Andorf Sandra¹⁸⁹^ORCID,Nadeau Kari C.¹^ORCID

Affiliation:

1. Sean N. Parker Center for Allergy and Asthma Research Stanford CA USA

2. Human Immune Monitoring Center Institute for Immunity, Transplantation, and Infection Stanford University School of Medicine Stanford CA USA

3. Division of Immunology Department of Pediatrics Boston Children's Hospital Boston MA USA

4. Department of Pediatrics Harvard Medical School Boston MA USA

5. Department of Microbiology and Immunology Stanford University School of Medicine Stanford CA USA

6. Department of Pathology Stanford University School of Medicine Stanford CA USA

7. Department of Biomedical and Data Science Stanford University Stanford CA USA

8. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA

9. Divisions of Biomedical Informatics and Allergy & Immunology Cincinnati Children’s Hospital Medical Center Cincinnati OH USA

Funder

National Institutes of Health

Simons Foundation

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14833

Reference47 articles.

1. The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States

2. Epidemiology of food allergy and food-induced anaphylaxis

3. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy

4. Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy

5. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immunobiology and Treatment of Food Allergy;Annual Review of Immunology;2024-06-28

2. Effects of Flavourzyme and Alkaline Protease Treatment on Structure and Allergenicity of Peanut Allergen Ara h 1;Food Technology and Biotechnology;2024-01-02

3. Oral immunotherapy for multiple food allergies;Encyclopedia of Food Allergy;2024

4. Hot topics in allergen immunotherapy, 2023: Current status and future perspective;Allergy;2023-11-20

5. Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand;Frontiers in Allergy;2023-10-02